We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

12 hedge funds and large institutions have $870K invested in Sonoma Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

33% less funds holding

Funds holding: 18 → 12 (-6)

38% less capital invested

Capital invested by funds: $1.41M → $870K (-$540K)

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
12
Holders Change
-6
Holders Change %
-33.33%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BRWA
B. Riley Wealth Advisors
Florida
+$39.5K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$14K
3
Wells Fargo
Wells Fargo
California
+$14K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$9.3K
5
MAS
Madden Advisory Services
Florida
+$2.33K

Top Sellers

Rank Fund Capital Flow
1
NL
NWAM LLC
Washington
-$117K
2
BA
Bard Associates
Illinois
-$59K
3
Barclays
Barclays
United Kingdom
-$54K
4
RCM
Rotella Capital Management
Washington
-$54K
5
Jane Street
Jane Street
New York
-$30.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$587K +$9.3K +4 +1%
BRWA
2
B. Riley Wealth Advisors
Florida
$138K +$39.5K +17 +35%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$57K +$14K +6 +29%
Jane Street
4
Jane Street
New York
$28K -$30.2K -13 -50%
Wells Fargo
5
Wells Fargo
California
$15K +$14K +6 +600%
Bank of America
6
Bank of America
North Carolina
$10K – – –
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$10K – – –
Morgan Stanley
8
Morgan Stanley
New York
$8K -$6.98K -3 -43%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$8K – – –
U
10
UBS
Switzerland
$5K -$9.3K -4 -67%
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$2K – – –
NES
12
New England Securities
New York
$1K – – –
MAS
13
Madden Advisory Services
Florida
$1K +$2.33K +1 New
NL
14
NWAM LLC
Washington
– -$117K -42 Closed
BA
15
Bard Associates
Illinois
– -$59K -21 Closed
Barclays
16
Barclays
United Kingdom
– -$54K -20 Closed
RCM
17
Rotella Capital Management
Washington
– -$54K -19 Closed
VIA
18
Vantage Investment Advisors
Pennsylvania
– -$9K -3 Closed
TRCT
19
Tower Research Capital (TRC)
New York
– -$4.65K -2 Closed
PNC Financial Services Group
20
PNC Financial Services Group
Pennsylvania
– -$3K -1 Closed

SNOA Hedge Fund Activity: Q3 2014 in Review

12 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2014, worth a combined $870K — down 38% from $1.41M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SNOA and 1 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 4 added.

The largest buyer was B. Riley Wealth Advisors, adding an estimated $39.5K. The largest seller was NWAM LLC, exiting entirely with an estimated $117K sold.

  • 12 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2014, down from 18 in Q2 2014.
  • Funds reported $870K of Sonoma Pharmaceuticals stock for Q3 2014, down 38% quarter-over-quarter.
  • 1 fund opened new Sonoma Pharmaceuticals positions in Q3 2014 and 7 closed out, a net change of -6 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q3 2014 was B. Riley Wealth Advisors, an estimated $39.5K added.
  • The largest Sonoma Pharmaceuticals seller in Q3 2014 was NWAM LLC, an estimated $117K sold.

Based on aggregated 13F filings for Q3 2014.